Stress-reducing Intervention in Urothelial Carcinoma

The aim of this interventional study is to test the heart-rate variability biofeedback intervention (HRV BI) in patients with muscle-infiltrating bladder carcinoma (MIBC) treated with chemotherapy based on cisplatin in neoadjuvant setting followed by local therapy (standard of care, SOC) compared to SOC alone.

NCT Number	NCT06269536
Lead Sponsor	Comenius University
Conditions	Bladder Cancer
Enrollment	50 participants
Start Date	2024-02-15
Primary Completion	2027-02-15 (estimated)
Study Completion	2029-02-15 (estimated)
Updated on ClinicalTrials.gov	2024-02-21